Impact of the obesity epidemic on hypertension and renal disease

[1]  M. Esler,et al.  Interactions Between Leptin and the Human Sympathetic Nervous System , 2003, Hypertension.

[2]  S. Oparil.  Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Practical Implications , 2003, Hypertension.

[3]  John E Hall,et al.  The kidney, hypertension, and obesity. , 2003, Hypertension.

[4]  J. Kuo,et al.  Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function , 2003, Hypertension.

[5]  John E. Hall,et al.  Obesity-associated hypertension and kidney disease , 2003, Current opinion in nephrology and hypertension.

[6]  E. Morales,et al.  Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  S. Beske,et al.  Sympathetic Neural Activation in Visceral Obesity , 2002, Circulation.

[8]  Megan Jehn,et al.  Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT). , 2002, Hypertension.

[9]  Arya M. Sharma,et al.  Angiotensin blockade prevents type 2 diabetes by formation of fat cells. , 2002, Hypertension.

[10]  Katherine M Flegal,et al.  Prevalence and trends in overweight among US children and adolescents, 1999-2000. , 2002, JAMA.

[11]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[12]  S. Daniels,et al.  Obesity hypertension in children: a problem of epidemic proportions. , 2002, Hypertension.

[13]  Ralph B D'Agostino,et al.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. , 2002, Archives of internal medicine.

[14]  Daniel W. Jones,et al.  Mechanisms of obesity-associated cardiovascular and renal disease. , 2002, The American journal of the medical sciences.

[15]  Daniel W. Jones,et al.  What can we do about the "epidemic" of obesity. , 2002, American journal of hypertension.

[16]  E. Jéquier.  Leptin Signaling, Adiposity, and Energy Balance , 2002, Annals of the New York Academy of Sciences.

[17]  John E. Hall,et al.  Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity , 2002, Hypertension.

[18]  G. Mancia,et al.  Participation of the Hypothalamus-Hypophysis Axis in the Sympathetic Activation of Human Obesity , 2001, Hypertension.

[19]  M. Esler,et al.  Sympathetic nervous system and insulin resistance: from obesity to diabetes. , 2001, American journal of hypertension.

[20]  A. Ribeiro,et al.  Treatment of obesity hypertension and diabetes syndrome. , 2001, Hypertension.

[21]  N. Abate,et al.  Overweight and Sympathetic Overactivity in Black Americans , 2001, Hypertension.

[22]  Daniel W. Jones,et al.  Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects , 2001 .

[23]  S. Bigler,et al.  Functional and structural changes in the kidney in the early stages of obesity. , 2001, Journal of the American Society of Nephrology : JASN.

[24]  J. Hall,et al.  Obesity hypertension: role of leptin and sympathetic nervous system. , 2001, American journal of hypertension.

[25]  T. Pischon,et al.  Choice of drug treatment for obesity-related hypertension: where is the evidence? , 2001, Journal of hypertension.

[26]  V. D’Agati,et al.  Obesity-related glomerulopathy: an emerging epidemic. , 2001, Kidney international.

[27]  A. Mark,et al.  Leptin Acts in the Central Nervous System to Produce Dose-Dependent Changes in Arterial Pressure , 2001, Hypertension.

[28]  J. Stern,et al.  Calorie restriction in obesity: prevention of kidney disease in rodents. , 2001, The Journal of nutrition.

[29]  S. Pudaric,et al.  Cardiovascular Disease Risk Factors Among Older Black, Mexican‐American, and White Women and Men: An Analysis of NHANES III, 1988–1994 , 2001, Journal of the American Geriatrics Society.

[30]  A. Dobrian,et al.  Oxidative Stress in a Rat Model of Obesity-Induced Hypertension , 2001, Hypertension.

[31]  O. B. Jones,et al.  Inhibition of NO Synthesis Enhances Chronic Cardiovascular and Renal Actions of Leptin , 2001, HYPERTENSION.

[32]  J. Rodicio,et al.  Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. , 2000, Kidney international.

[33]  E. Ravussin,et al.  Ethnic Differences in Insulinemia and Sympathetic Tone as Links Between Obesity and Blood Pressure , 2000, Hypertension.

[34]  G. Mancia,et al.  Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension , 2000, Hypertension.

[35]  J. Karlberg,et al.  Blood pressure is associated with body mass index in both normal and obese children. , 2000, Hypertension.

[36]  K. Hosoda,et al.  Pathophysiological role of leptin in obesity-related hypertension. , 2000, The Journal of clinical investigation.

[37]  P. Whelton,et al.  Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. , 2000, Hypertension.

[38]  A. Mark,et al.  Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. , 1999, Journal of hypertension.

[39]  J Licinio,et al.  Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defe , 1999, The Journal of clinical endocrinology and metabolism.

[40]  S. Wannamethee,et al.  Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. , 1999, Diabetes care.

[41]  C. Rotimi,et al.  The puzzle of hypertension in African-Americans. , 1999, Scientific American.

[42]  B. Falkner,et al.  Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group. , 1997, Hypertension.

[43]  J. Granger,et al.  Renal denervation attenuates the sodium retention and hypertension associated with obesity. , 1995, Hypertension.

[44]  G. Assmann,et al.  The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. , 1988, American heart journal.

[45]  W. Kannel,et al.  Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. , 1987, Preventive medicine.

[46]  A. Mark,et al.  Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. , 1999, Hypertension.

[47]  J. Hall,et al.  Chronic leptin infusion increases arterial pressure. , 1998, Hypertension.